Latest filing published 08 Aug 2019 for ReShape Lifesciences Inc., €8,923.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Amy VandenBerg: trading record in brief
Amy VandenBerg discloses dealings in ReShape Lifesciences Inc. to SEC (Form 4). Over a trading history stretching from 2 January 2018 to 6 August 2019, the count stands at 7 filings.
On the market, this insider has only ever bought: 1 purchase, €8,923 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants and 3 option exercises. So far in 2019, the count stands at 1 purchase and no sales.
The latest filing, published on 8 August 2019, reports an open-market purchase of €8,923 in ReShape Lifesciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Amy VandenBerg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$4.0034.0% of flowCommon StockSEC:0001214659-19-005087:0Canonical exit: 4 Nov 2019 (T+90)
- 10,989 shares@ US$1.8255.1% of flowCommon StockSEC:0001214659-18-005738:0
- 15,000 shares0Common Stock (Restricted Stock Award)SEC:0001214659-18-003873:0
- 4,022 shares@ US$0.879.0% of flowCommon StockSEC:0001214659-18-000757:0
- 1,087 shares@ US$0.872.4% of flowCommon StockSEC:0001214659-18-000757:1
- 1,541 shares@ US$1.315.2% of flowCommon StockSEC:0001214659-18-000757:2
- 60,000 shares0Common Stock (Restricted Stock Award)SEC:0001214659-18-000184:0
7 of 7 declarations